(T) 1.949.553.7541

Rod Anavim is an experienced corporate attorney with a practice focusing on mergers and acquisitions, debt and equity financing transactions, securities law compliance, joint ventures, corporate governance matters, and commercial agreements. He has significant experience representing a range of parties, including buyers, sellers, and financial advisors.

Prior to joining Jones Day in 2014, Rod was the general counsel of a group of companies that specialize in the acquisition, consolidation, and operation of insurance services businesses.


Hitachi Vantara acquires REAN Cloud
Jones Day advised Hitachi Vantara in its acquisition of REAN Cloud LLC, a global cloud systems integrator, managed services provider and solutions developer of cloud-native applications across big data, machine learning and emerging internet of things (IoT) spaces.

VMware acquires CloudHealth Technologies
Jones Day advised VMware, Inc in its acquisition of CloudHealth Technologies, Inc.

Hookit raises capital in Series C round
Jones Day represented Hookit, a leading sponsorship analytics and valuation platform, in connection with the sale and issuance of $16 million of Series C Preferred Stock and concurrent tender offer to the holders of its junior preferred securities.

Entravision Communications acquires Headway
Jones Day advised Entravision Communications Corporation in its acquisition of Headway, a leading provider of mobile, programmatic, data, and performance digital marketing solutions primarily in Argentina, Mexico, and the rest of Latin America, the United States, Spain, and Israel.

Sumitomo Dainippon Pharma acquires Tolero Pharmaceuticals, Inc.
Jones Day advised Sumitomo Dainippon Pharma Co. Ltd., a leading pharmaceutical company based in Japan, in its acquisition of Tolero Pharmaceuticals, Inc.

Lam Research attempts merger with KLA-Tencor
Jones Day represented Lam Research Corporation in its proposed acquisition of all outstanding shares of KLA-Tencor Corporation in a cash and stock transaction that placed an equity value on KLA-Tencor of approximately $10.6 billion based on its closing stock price on October 20, 2015.

Astellas sells U.S. manufacturing subsidiary to Avara
Jones Day advised Astellas Pharma Inc. in the transfer of its wholly owned manufacturing subsidiary Astellas Pharma Technologies, Inc. to Avara Norman Pharmaceutical Services, Inc.

Specialty Silicone Fabricators sold to Trelleborg AB
Jones Day advised Specialty Silicone Fabricators, Inc., a California-based manufacturer of high-precision silicone components for medical technology original equipment manufacturers, in connection with the sale of all of the company's outstanding stock and real estate owned by certain entities related to shareholders of the company to Trelleborg AB, a Sweden-based leader in engineered polymer solutions.

Abbott purchases option to acquire Cephea Valve Technologies
Jones Day advised Abbott Laboratories in the providing of capital and securing of an option to purchase Cephea Valve Technologies, a private company developing a catheter-based mitral valve replacement therapy.

BioMarin acquires Prosensa Holding N.V. for $680 million
Jones Day advised BioMarin Pharmaceutical Inc. in its acquisition of Prosensa Holding N.V., a public, biotechnology company, focused on the discovery and development of RNA-modulating therapeutics for the treatment of rare genetic disorders.

The following represents experience acquired prior to joining Jones Day.


Represented Kraft Foods in its cross-border tender offer acquisition of Cadbury plc for approximately $18.4 billion, including in connection with no-action and exemptive relief from certain provisions of the Securities Exchange Act of 1934.

Represented American Capital in various leveraged buyout acquisitions of portfolio companies.

Represented Quidel Corporation in its acquisition of Diagnostic Hybrids for approximately $130 million.

Represented U.S. Pathology Labs in its sale to Laboratory Corporation of America Holdings for approximately $155 million.

Represented International Game Technology in its acquisition of Wager Works for approximately $90 million.

Represented QLogic Corporation in its acquisition of SilverStorm Technologies for approximately $60 million.

Represented Specific Media in its acquisition of MySpace for approximately $35 million.

Represented Memorex Products in its sale to Imation Corporation for approximately $329 million plus contingent payments up to $45 million.

Represented Confie Seguros group of companies in its leveraged buyout with a new private equity investor and in 22 roll-up acquisitions of insurance services businesses.

Represented Fleetwood Enterprises as a bankrupt debtor in possession in various free and clear asset sales, including the sale of its motor home division assets to American Industrial Partners for approximately $53 million, the sale of its manufactured housing division assets to Cavco Industries for $37 million, and the sale of its military housing division assets to Clayton Homes for approximately $4.5 million.

Represented Westar Capital in its sale of Soff-Cutt International (a leading producer of concrete saws) to Husqvarna for an undisclosed amount.

Corporate Finance

Represented Fleetwood Enterprises in its registered $100 million debt-for-debt exchange offer.

Represented Nationwide Health Properties in its shelf registration statement for various securities, its offering of 5,000,000 shares of common stock, and its tender offer for $223 million of its debt securities.

Represented Allergan in its shelf registration statement for various securities.

Represented JP Morgan, Bank of America, Morgan Stanley, and Deutsche Bank, as dealer managers, in connection with AMB Property's tender offer to purchase $250 million of its debt securities.

Represented Textron in its tender offer to purchase $650 million of its debt securities.

Represented Eastman Kodak in its tender offer to purchase $200 million of its debt securities.

Represented Del Monte Foods Company in its stock buyback program with Goldman Sachs for $100 million.

Represented Atmos Energy Corporation in its stock buyback program with Goldman Sachs for $100 million.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.